Effectiveness of pharmaceutical interventions for meibomian gland dysfunction: An evidence-based review of clinical trials
| Autor: | Pauline Khoo, Stephanie L Watson, Kenneth G.-J. Ooi |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Population Psychological intervention Disease 03 medical and health sciences 0302 clinical medicine medicine Humans 030212 general & internal medicine education Blepharitis Intensive care medicine Glucocorticoids Meibomian Gland Dysfunction Clinical Trials as Topic education.field_of_study Evidence-Based Medicine integumentary system business.industry Meibomian gland dysfunction medicine.disease Evidence based review Anti-Bacterial Agents Clinical trial Ophthalmology Treatment Outcome Pharmaceutical Preparations Clinical evidence Dietary Supplements 030221 ophthalmology & optometry sense organs business Immunosuppressive Agents |
| Zdroj: | Clinical & Experimental Ophthalmology. 47:658-668 |
| ISSN: | 1442-6404 |
| DOI: | 10.1111/ceo.13460 |
| Popis: | Meibomian gland dysfunction is one of the most common ocular disorders encountered by ophthalmologists and is the leading cause of evaporative dry eye. The disease causes significant morbidity in the population such that patients seek treatment. Multiple clinical studies on pharmacological and mechanical interventions for the treatment of meibomian gland dysfunction have been evaluated. However, there is limited comparative clinical evidence for the effectiveness of these interventions. This review paper aims to report the clinical evidence for pharmaceutical interventions for meibomian gland dysfunction in order to guide clinicians in the management of the disease. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |